Betamethasone Dipropionate/Butenafine

倍他米松二丙酸酯/布替萘芬

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBetamethasone Dipropionate/Butenafine

Drug Alias NameButenafine/Betamethasone Dipropionate布替萘芬/倍他米松二丙酸酯Betamethasone Dipropionate and Butenafine布替萘芬倍他米松二丙酸酯Butenafine and Betamethasone Dipropionate

ClassificationSmall molecules > Steroids

Mechanisms of ActionGlucocorticoid receptor agonistsSqualene monooxygenase inhibitors

TargetsGlucocorticoid receptorSqualene monooxygenase

Therapy Area/IndicationsTinea Pedis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsYes Butenafine Hydrochloride Betamethasone Dipropionate

Global Highest StatusDiscontinued (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesMylan Nv

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMylan Nv

Active IndicationsN/A

Inactive IndicationsTinea Pedis

Other Information

ATC CodeN/A